The pharmaceutical landscape for glucose is shifting, and transdermal GLP-1 delivery systems represent a promising advance. Unlike injections, this approach offers a more convenient way to deliver GLP-1 therapies. https://rsaains013959.rimmablog.com/39746093/glp-1-patches-a-novel-approach-to-diabetes-treatment